Larimar Therapeutics to Host Conference Call on Friedreich’s Ataxia Updates
BALA CYNWYD, PA — Larimar Therapeutics, Inc. (Nasdaq: LRMR) announced a conference call and webcast to discuss regulatory updates for the nomlabofusp clinical development program for Friedreich’s Ataxia on Monday, …
Larimar Therapeutics to Host Conference Call on Friedreich’s Ataxia Updates Read More